SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bliss GVS Pharma submits copy of scrutinizer report

25 Sep 2015 Evaluate

Bliss GVS Pharma has submitted a copy of the scrutinizer report of e-voting & poll for declaring the result of 30th Annual General Meeting of the Company held on September 16, 2015.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

264.35 -4.60 (-1.71%)
24-Apr-2026 09:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.90
Dr. Reddys Lab 1326.25
Cipla 1290.60
Zydus Lifesciences 942.85
Lupin 2338.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×